Document is current
Any future updates will be listed below
-
Authors
Himeno, Tatsuhito https://orcid.org/0000-0002-5677-1125
Nakai-Shimoda, Hiromi
Hayashi, Yusuke
Matsumae, Akihiro
Kamiya, Hideki
Nakamura, Jiro
Matsumae, Hiromi
- License Information
-
More Information
Article History
Received: 25 July 2024
Accepted: 23 May 2025
First Online: 3 June 2025
Declarations
:
: Tatsuhito Himeno, Hiromi Nakai-Shimoda, Yusuke Hayashi, Akihiro Matsumae, and Hiromi Matsumae declare that they have no conflict of interest. Hideki Kamiya received lecture fees from Novo Nordisk Pharma, Sanofi, Sumitomo Pharma, Nippon Boehringer Ingelheim, Eli Lilly Japan, Daiichi Sankyo, Ono Pharmaceutical, Kissei Pharmaceutical, Mitsubishi Tanabe Pharma, Kowa, Novartis Pharma, MSD, and Sanwa Kagaku Kenkyusho and research funding from Eli Lilly Japan, Ono Pharmaceutical, Kissei Pharmaceutical.
: All procedures were in accordance with the Helsinki Declaration of 1964 and later versions. Informed consent was obtained from the patient for being included in the report.
